(Q38124282)

29 August 2017

title

Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis (English)

1 reference

interstitial lung disease

29 August 2017

main subject

1 reference

Patrick D W Kiely

1

1 reference

29 August 2017

Felix Chua

series ordinal

2

1 reference

29 August 2017

publication date

1 September 2013

1 reference

Current Rheumatology Reports

29 August 2017

published in

1 reference

29 August 2017

volume

15

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

359

1 reference

Interstitial pneumonitis in dermatomyositis.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Pulmonary disease in polymyositis/dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Polymyositis-dermatomyositis-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Calprotectin is released from human skeletal muscle tissue during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0359-6

Interstitial lung disease in polymyositis and dermatomyositis

21 January 2018

1 reference

12 December 2020

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

1 reference

12 December 2020

Antibody to signal recognition particle in polymyositis

1 reference

12 December 2020

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

1 reference

12 December 2020

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

1 reference

12 December 2020

Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies

1 reference

12 December 2020

Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.

1 reference

12 December 2020

MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases

1 reference

12 December 2020

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody

1 reference

12 December 2020

In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease

1 reference

12 December 2020

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis

1 reference

12 December 2020

Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings

1 reference

12 December 2020

Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT

1 reference

12 December 2020

Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort

1 reference

12 December 2020

Pulmonary involvement in polymyositis and in dermatomyositis

1 reference

12 December 2020

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

12 December 2020

Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease.

1 reference

12 December 2020

Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients

1 reference

12 December 2020

Serum KL-6 in adult patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

1 reference

12 December 2020

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

1 reference

12 December 2020

Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings

1 reference

12 December 2020

Interstitial Pneumonitis in Association with Polymyositis and Dermatomyositis

1 reference

12 December 2020

Long-term prognosis of 69 patients with dermatomyositis or polymyositis

1 reference

12 December 2020

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

12 December 2020

10.1007/S11926-013-0359-6

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1016166332

0 references

1 reference